For the second time in 6 months, the Centers for Medicare & Medicaid Services officials have revised readmission penalties for hospitals. In doing so, approximately 1200 hospitals are now subject to lesser penalties.
For the second time in 6 months, the Centers for Medicare & Medicaid Services (CMS) officials have revised readmission penalties for hospitals. In doing so, approximately 1200 hospitals are now subject to lesser penalties.
The new corrections include decreased penalties for 1246 hospitals and increased penalties for 226 hospitals, resulting in a total of $280 million in penalties, which is approximately $10 million less than previously calculated. Kaiser Health News also released the following information following an analysis of the new data:
According to Jonathan Blum, Acting Principal Deputy Administrator and Director, Center for Medicare and CMS, stated that “This decrease is an early sign that our payment and delivery reforms are having an impact.” Kaiser Health News adds that “Under the program, the government is looking at the number of heart attack, heart failure, and pneumonia patients who return to the hospital within 30 days of discharge,” and that “hospitals with more readmissions than Medicare expected given their mix of patients are penalized by losing up to 1% of their regular payments.”
Around the Web
Medicare Revises Readmissions Penalties — Again [Kaiser Health News]
CMS Revises Hospitals' Readmission Penalties for the Second Time [Becker’s Hospital Review]
Low Pulmonary Rehabilitation, Palliative Care Referrals for Patients With IPF Persist
October 30th 2024Despite proven benefits, referrals to pulmonary rehabilitation and palliative care for patients with idiopathic pulmonary fibrosis (IPF) in England remain significantly lower than for other respiratory conditions.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen